CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Original notice title
Malta – Toxins – CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
45 / 100
Risk factors
Award criteria and selection criteria are not disclosed, making bid preparation speculative.
Framework contract may not guarantee any minimum purchase volume.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Department of Contracts
- Country
- Malta
- CPV
- 33693100 - Toxins
- Deadline
- Jul 15, 2026
- Estimated value
- EUR 5.6M
Overview
Moderate opportunityKey Facts
- EUR 5.6M estimated value
- Supplies contract
- 1 lot
- Supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for Inflammatory Bowel Disease (IBD)
- Framework contract; no quantities or minimum spend specified
Show full summary
This is an open procedure framework contract for the supply of selective Janus Kinase 1 inhibitor tablets/prolonged release tablets/capsules for inflammatory bowel disease (IBD). The contract is for a single lot with an estimated total value of €5,608,254.60. The buyer is the Department of Contracts in Malta. The deadline for submission is 15 July 2026 at 07:30 (Malta time). Electronic submission is required in English. The notice does not disclose award or selection criteria; only an ESPD (European Single Procurement Document) is referenced. No procurement documents were analyzed beyond the notice.
Risks
Award criteria and selection criteria are not disclosed, making bid preparation speculative.
Framework contract may not guarantee any minimum purchase volume.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must supply pharmaceutical products classified under CPV 33693100
Administrative
- Electronic submission via eTenders Malta portal
- Tender must be submitted in English
Requirements may be incomplete.
Buyer
Location
Floriana, MLT
Website
Buyer profile
Identifier
MT25645419
Activity
General public services
Lots (1)
LOT-0001
CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Supply of selective JAK1 inhibitor tablets/prolonged release tablets/capsules for IBD.
EUR 5.6M
Estimated value
Location
Category
Deadline
Award details
CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Value note
Show original TED data
Original TED description
CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Procurement Details
- Publication date
- 10 Jun 2026
- Languages
- English
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 400302-2026
Documents (2)
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
45 / 100
Risk factors
Award criteria and selection criteria are not disclosed, making bid preparation speculative.
Framework contract may not guarantee any minimum purchase volume.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications